Advertisement

Topics

Bench to Bedside and Back Again May Be Key to Clinical Breakthroughs

20:00 EDT 3 Jul 2017 | JAMA

Very few treatments tested in preclinical studies make their way into clinical trials—of 5000 compounds tested in animals, approximately 5 will show enough promise in human trials for a company to file an Investigational New Drug Application with the US Food and Drug Administration.

Original Article: Bench to Bedside and Back Again May Be Key to Clinical Breakthroughs

NEXT ARTICLE

More From BioPortfolio on "Bench to Bedside and Back Again May Be Key to Clinical Breakthroughs"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...